Web Access Research Portal

Researcher: Bereznicki, LRE (Professor Luke Bereznicki)

Fields of Research

Clinical pharmacy and pharmacy practice
Pharmaceutical sciences
Clinical pharmacology and therapeutics
Health services and systems
Basic pharmacology
Cardiology (incl. cardiovascular diseases)
Pharmacology and pharmaceutical sciences
Respiratory diseases
Health and community services
Preventative health care
Haematology
Health informatics and information systems
Primary health care
Aged health care
Paediatrics
Cardiovascular medicine and haematology
Residential client care
Medicine, nursing and health curriculum and pedagogy
Health promotion
Health counselling
Health care administration
Geriatrics and gerontology
Aboriginal and Torres Strait Islander public health and wellbeing
Community child health
Community and primary care
Nephrology and urology
Higher education
Infant and child health
Traditional, complementary and integrative medicine
Pathology (excl. oral pathology)
Intensive care
Pharmacogenomics
Rheumatology and arthritis
Public health nutrition
Oncology and carcinogenesis
Medical biochemistry and metabolomics
Orthopaedics
Toxicology (incl. clinical toxicology)
Service oriented computing
Infectious diseases
Clinical sciences
Orthodontics and dentofacial orthopaedics
Pain
Acute care

Research Objectives

Other health
Clinical health
Diagnosis of human diseases and conditions
Evaluation of health outcomes
Preventive medicine
Health education and promotion
Health related to ageing
Evaluation of health and support services
Expanding knowledge in the health sciences
Neonatal and child health
Treatment of human diseases and conditions
Allied health therapies (excl. mental health services)
Human pain management
Prevention of human diseases and conditions
Efficacy of medications
Behaviour and health
Public health (excl. specific population health)
Rural and remote area health
Primary care
Provision of health and support services
Health policy evaluation
Assessment, development and evaluation of curriculum
Specific population health (excl. Indigenous health)
Teaching and instruction technologies
Nursing
Learner and learning
Nutrition
Other education and training
Other information and communication services
Men's health

Career Best Publications

Research Publications

A computer simulation of community pharmacy practice for educational use; American Journal of Pharmaceutical Education
A flexible anticoagulation monitoring service for rural community pharmacies: a pilot study; National Medicines Symposium 2010
A flexible anticoagulation monitoring service for rural community pharmacies: A pilot study; Pharmacy Australia Congress 2010
A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial); Journal of Clinical Pharmacy and Therapeutics
A novel multi-mode education program to enhance asthma care by pharmacists; American journal of pharmaceutical education
A pilot study of warfarin home monitoring with electronic communication to primary care; Australian Disease Management Association 3rd Annual National Disease Management Conference. Disease Management: Is it worth it?
A pilot study of warfarin home-monitoring with electronic communication to primary care; Medicines design to delivery
A qualitative analysis of warfarin management after discharge from hospital; Pharmacy Practice Research Summit 2010
A retrospective review of pain management in Tasmanian residential aged care facilities; BJGP Open
A review of the initiation of anticoagulation: does lack of adherence to guidelines result in an increased risk of adverse outcomes?; 4th Biennial SHPA Clinical Conference
A review of the initiation of anticoagulation: does lack of adherence to guidelines result in an increased risk of adverse outcomes?; Annual Scientific Meeting. The Haematology Society of Australia and New Zealand, the Australian and New Zealand Society of Blood Transfusion and The Australisian Society of Thrombosis and Haemostasis
A review of the management of childhood asthma in Tasmania; APSA 2011 Annual Conference
A role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study; BMC Health Services Research
A summary of the literature evaluating adherence and persistence with oral anticoagulants in atrial fibrillation; American Journal of Cardiovascular Drugs
A targeted approach to improve asthma control using community pharmacists; Frontiers in Pharmacology
A web-based training program to support chronic kidney disease screening by community pharmacists; International Journal of Clinical Pharmacy
Accuracy and clinical usefulness of the near-patient testing CoaguChek S international normalised ratio monitor in rural medical practice; Australian Journal of Rural Health
Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring; Journal of Clinical Pathology
Accuracy, reproducibility and clinical utility of the CoaguChek S portable international normalized ratio monitor in an outpatient anticoagulation clinic; Clinical and Laboratory Haematology
Actual drug-related harms in residential aged care facilities: a narrative review; Expert Opinion on Drug Safety
Adherence to antiretroviral drug therapy in adult patients who are HIV-positive in Northwest Ethiopia: a study protocol; BMJ Open
Adherence to antiretroviral therapy and virologic failure; Medicine
Adherence to management guidelines for childhood asthma in Australia; Australian Family Physician
Adherence to oral anticoagulants in atrial fibrillation: an Australian survey; Journal of Cardiovascular Pharmacology and Therapeutics
Adverse drug events and the role of the pharmacy; Australian Pharmacist
Adverse drug reaction-related hospitalisation in older patients - A prospective analysis in two hospitals; APSA Annual Conference 2016
Adverse drug reaction-related hospitalisations among people with dementia; APSA-ASCEPT 2022 Joint Conference
Adverse drug reaction-related hospitalizations in elderly Australians: A prospective cross-sectional study in two Tasmanian hospitals; Drug Safety
Adverse drug reactions and clinical outcomes in patients initiated on antiretroviral therapy: a prospective cohort study from Ethiopia; Drug Safety
Adverse effects associated with gabapentinoids in persistent pain; Pharmacy Australia Congress
Adverse-drug-reaction-related hospitalisations in developed and developing countries: a review of prevalence and contributing factors; Drug Safety
An evaluation of pharmacist-assisted anticoagulant monitoring after initiation of warfarin in the transition from hospital to community care; National Medicines Symposium 2006 - Quality use of medicines: balancing beliefs, benefits and harms
An important role for community pharmacy in reducing evidence gaps; Australian Pharmacist
An intervention to improve adherence to an initiation protocol and improve clinical outcomes for patients commenced on warfarin; National Medicines Symposium 2006 - Quality use of medicines: balancing beliefs, benefits and harms
An intervention to improve clinical outcomes for inpatients commenced on warfarin; The Society of Hospital Pharmacists of Australia 5th Biennial Clinical Conference
An online person-centered education package for pharmacists delivering a home medication review service to patients following acute coronary syndromes; European Journal for Person Centered Healthcare
An update on atrial fibrillation; Australian Pharmacist
An update on INR monitoring; Australian Pharmacist
Anti-thrombotics Essential CPE- Continuing education from the Pharmaceutical Society of Australia; Pharmaceutical Society of Australia
Antibiotics for acute otitis media in children; Australian Pharmacist
Anticoagulant therapy in the elderly: the importance of health literacy; Australian Pharmacist
Anticoagulant use in patients with nonvalvular atrial fibrillation: has prescribing improved?; Clinical and Applied Thrombosis/Hemostasis
Anticoagulation for people receiving long-term haemodialysis; Cochrane Database of Systematic Reviews
Anticoagulation in atrial fibrillation; Australian Pharmacist
Anticoagulation knowledge in patients with atrial fibrillation: an Australian survey; International journal of clinical practice
Anticoagulation monitoring services; Australian Pharmacist
Anticoagulation patient self-monitoring; Pharmacy Australia Congress 2009
Antioxidants and the prevention of cancer; Australian Pharmacist
Antiretroviral adherence and treatment outcomes among adult Ethiopian patients; 2015 Joint APSA-ASCEPT Annual Conference
Antiretroviral adherence and treatment outcomes among adult Ethiopian patients; 2015 Joint APSA-ASCEPT Annual Conference
Antiretroviral adherence and treatment outcomes among adult Ethiopian patients; Aids Care
Antithrombotics Essential CPE; Pharmaceutical Society of Australia Ltd.
Antithrombotics: How pharmacists can optimise outcomes; Pharmacy Expo 2009
Applying the Capability, Opportunity, and Motivation Behaviour Model (COM-B) to Guide the Development of Interventions to Improve Early Detection of Atrial Fibrillation; Clinical Medicine Insights: Cardiology
Are the national orthopaedic thromboprophylaxis guidelines appropriate?; ANZ Journal of Surgery
Assessing risk of adverse drug reactions in the elderly: a feasibility study; International Journal of Clinical Pharmacy
Association between anticholinergic drug burden and mortality in older people: a systematic review; European Journal of Clinical Pharmacology
Association between anticholinergic drug burden and mortality in older people: an evidence-based approach; 79th FIP World Congress of Pharmacy and Pharmaceutical Sciences
Atrial fibrillation: keeping the beat; Pharmacy Expo 2011
Attempting to change practice: challenges and rewards; The 36th SHPA National Conference - Staying Alive - Medicines Mangement
Authors' Reply to Mona Kargar and Colleagues' Comment on 'Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals'; Drug Safety
Authors’ Reply to Cotton and Nicol’s Comment on ‘‘Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study from Ethiopia’’; Drug Safety
Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia; PLoS One
Barriers to INR self-monitoring in mechanical heart valve recipients: a qualitative study; Medical Management 2011 The 37th national Conference
Barriers to optimal pain management in aged care facilities: an Australian qualitative study; Pain Management Nursing
Beta-blockers in asthma; Australian Pharmacist
Bisphosphonates and osteomyelitis of the jaw; Australian Pharmacist
Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation (TAF) study; European Journal of Clinical Pharmacology
Calcium and vitamin D in osteoporosis; Australian Pharmacist
Changes in oral anticoagulant prescribing for stroke prevention in patients with atrial fibrillation; American Journal of Cardiology
Changes to HMR business rules; Australian Pharmacist
Characteristics and short-term outcomes of Royal Hobart Hospital patients discharged on warfarin; Society of Hospital Pharmacists of Australia, Tasmanian Branch, Symposium 2009
Clinical outcomes and cost-effectiveness of a pharmacy-led post-discharge warfarin management service; Australasian Pharmaceutical Science Association Annual Conference 2010 Focus on the Future: Research and education for a healthier community
Clinical Outcomes of a Collaborative, Home-Based Postdischarge Warfarin Management Service; The Annals of Pharmacotherapy
Clinical outcomes of a pharmacist-led post-discharge warfarin management service; 11th national conference on anticoagulant therapy
Clinicians’ attitudes and perceptions regarding stroke prevention in atrial fibrillation; 2015 Joint APSA-ASCEPT Annual Conference
Clinicians’ attitudes and perceptions regarding stroke prevention in atrial fibrillation; 2015 Joint APSA-ASCEPT Annual Conference
Clopidogrel and PPIs: what is the current evidence?; Australian Pharmacist
Clopidogrel prescribing and concordance with the Pharmaceutical Benefits Scheme in hospital patients; Journal of Pharmacy Practice and Research
Clopidogrel-aspirin combination for atrial fibrillation: CLAAF is not CLEAR; American Heart Journal
Closing the gap between evidence and practice; Journal of Pharmacy Practice and Research
Coenzyme Q10 and statin-associated myopathy; Australian Pharmacist
Combining aspirin and clopidogrel: when is one better than both?; Australian Pharmacist
Comment: Increased sensitivity to warfarin after heart valve replacement; The Annals of Pharmacotherapy
Community pharmacists’ knowledge and perspectives of reporting adverse drug reactions in Australia: a cross‑sectional survey; International Journal of Clinical Pharmacy
Comparing Australian orthopaedic surgeons' reported use of thromboprophylaxis following arthroplasty in 2012 and 2017; Bmc Musculoskeletal Disorders
Comparing the intervention of partnered pharmacist medication charting to early/late possible medication history; The 46th SHPA National Conference
Comparing the renal outcomes in patients with atrial fibrillation receiving different oral anticoagulants; Expert Review of Clinical Pharmacology
Consumer perspectives on INR self-monitoring; Pharmacy Australia Congress 2010
Consumer perspectives on INR self-monitoring; National Medicines Symposium 2010
Consumers' perceptions of a pharmacist-led post-discharge warfarin management service; Pharmacy Australia Congress 2010
Consumers' perceptions of a pharmacist-led post-discharge warfarin management service; National Medicines Symposium 2010 medicines in people’s lives
Consumers' perceptions of a pharmacist-led post-discharge warfarin management service; Pharmacy Australia Congress 2010
Dabigatran (Pradaxa) for atrial fibrillation; Annual Medicines Update 2011
Development and Validation of an Atrial Fibrillation Knowledge Assessment Tool (AFKAT); International Journal of Environmental Research and Public Health
Development and validation of an oral anticoagulant knowledge instrument; 2015 Joint APSA-ASCEPT Annual Conference
Development and validation of an oral anticoagulant knowledge instrument; APSA-ASCEPT 2015
Development and validation of an oral anticoagulation knowledge tool (AKT); PloS one
Development of a benchmarking tool for pharmacy students using threshold learning outcomes; APSA 2014 Annual Conference
Development of a benchmarking tool for pharmacy students using threshold learning outcomes; Teaching Matters 2014
Development of a flexible and extensible computer-based simulation platform for healthcare students; Studies in Health Technology and Informatics
Development of a Score to Predict Hospitalisation due to Adverse Drug Reactions in Older Patients; 2015 Joint APSA-ASCEPT Annual Conference
Development of a Score to Predict Hospitalisation due to Adverse Drug Reactions in Older Patients; 2015 Joint APSA-ASCEPT Annual Conference
Development of an innovative web based anticoagulation resource; Australasian Pharmaceutical Science Association Conference
Development of www.anticoagulation.com.au - A resource for anticoagulation therapy; Pharmacy Australia Congress 2010
Development of www.anticoagulation.com.au - a resource for anticoagulation therapy; National Medicines Symposium 2010
Development of wwww.anticoagulation.com.au - a resource for anticoagulation therapy; Pharmacy Practice Research Summit 2010
Diagnosis and management of early COPD in Australia: views from the coal face; 2015 Joint APSA-ASCEPT Annual Conference
Does prescribing of immediate release oxycodone by emergency medicine physicians result in persistence of Schedule 8 opioids following discharge?; Emergency medicine Australasia
Dopamine agonists in Parkinson's disease; Australian Pharmacist
Drug-Related Problems Detected in Australian Community Pharmacies: The PROMISe Trial; The Annals of Pharmacotherapy
Drug-related problems identified in post-discharge medication reviews for patients taking warfarin; International Journal of Clinical Pharmacy
Early outcomes of a pharmacist-led post-discharge warfarin management service; The Australasian Pharmaceutical Science Association Annual Conference Aus-CRS Symposium
Eating Disorders; Australian Pharmacist
Effect of a fucoidan extract on insulin resistance and cardiometabolic markers in obese, nondiabetic subjects: a randomized, controlled trial; Journal of Alternative and Complementary Medicine
Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial); Age and Ageing
Effectiveness of targeted screening for chronic kidney disease in the community setting: a systematic review; Journal of Nephrology
Efficacy of a Pharmacist-Managed Intervention for Improved Blood Pressure Control in Patients with Elevated Cardiovascular Disease Risk: Subgroup Analysis of the HAPPY RCT; Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart research Australasian Section Annual Scientific Meeting
Eight-year trends in direct-acting oral anticoagulant dosing, based on age and kidney function, in patients with atrial fibrillation; Journal of Patient Safety
Emergency department presentations of febrile children to an Australian public hospital; Journal of Paediatrics and Child Health
Encouraging periconceptional use of folic acid supplements; Australian Pharmacist
Encouraging the rational use of probiotics in combination with antibiotics - what are we trying to prevent?; Australian Pharmacist
Ensuring accurate results in INR self-monitoring; Pathology Update 2010
Evaluation of a clinical pathway to enable patient self-monitoring of anticoagulation; HAA The Annual Scientific Meeting
Evaluation of a clinical pathway to enable patient self-monitoring of anticoagulation; APSA annual Conference Aus-CRS Symposium Hobart
Evaluation of a clinical pathway to enable patient self-monitoring of anticoagulation ; National Medicines Symposium 2010
Evaluation of a clinical pathway to enable patient self-monitoring of warfarin; Pharmacy Practice Research Summit 2010
Evaluation of antithrombotic usage for atrial fibrillation in aged care facilities; Journal of Clinical Pharmacy and Therapeutics
Evidence-practice gaps; Australian Pharmacist
Evidence-practice gaps; Australian Pharmacist
Evidence-to-practice gaps in the management of community-dwelling Australian patients with ischaemic heart disease; Journal of Clinical Pharmacy and Therapeutics
Exploring the quality of anticoagulant prescribed for patients with atrial fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia; Journal of cardiovascular pharmacology and therapeutics
External ear problems; Australian Pharmacist
Factors affecting wound healing; Australian Pharmacist
Factors associated with overestimation of asthma control: a crosssectional study in Australia; Journal of Asthma
Factors influencing oral anticoagulant use in patients newly diagnosed with atrial fibrillation; European Journal of Clinical Investigation
Five-year trends in potential drug interactions with direct-acting oral anticoagulants in patients with atrial fibrillation: an Australian-wide study; Journal of Clinical Medicine
Fungal foot infections; Australian Pharmacist
Gaps in anticoagulation knowledge in patients with atrial fibrillation; ASCEPT ASM / 2017 Annual Scientific Meeting
Glycaemic control in type 2 diabetes: what is the target?; Australian Pharmacist
Head Lice; Australian Pharmacist
Healthcare expenditure and its socio-demographic and clinical predictors in Australians with poorly controlled asthma; PLoS One
Heart Failure; Australian Pharmacist
Home Medicines Review following acute coronary syndromes: Preliminary results from a randomised controlled trial; 2015 Joint APSA-ASCEPT Annual Conference
Home medicines reviews following acute coronary syndrome: study protocol for a randomized controlled trial; Trials
Home medicines reviews in Australian war veterans taking warfarin do not influence international normalised ratio control; Internal Medicine Journal
Home-monitoring of warfarin (the ultimate strategy to improve the safety of anticoagulation); Australian Pharmacist
Hormone replacement therapy for menopause; Australian Pharmacist
Hospital readmission for major bleeding or thromboembolic complications in patients with atrial fibrillation; 2015 Joint APSA-ASCEPT Annual Conference
Hospital readmission for major bleeding or thromboembolic complications in patients with atrial fibrillation; 2015 Joint APSA-ASCEPT Annual Conference
Hospitalization in older patients due to adverse drug reactions - the need for a prediction tool; Clinical Interventions in Aging (Online)
How can pharmacists improve asthma control in the community?; Australian Pharmacist
How can pharmacists improve the management of warfarin therapy?; Australasian Pharmaceutical Science Association. Conference
How can pharmacists improve warfarin management along the continuum of care?; The 36th SHPA National Conference 2010 - Staying Alive - Medicines Management
How to read and interpret clinical trials; Australian Pharmacist
Hypertension; Australian Pharmacist
Hypertension; Australian Pharmacist
Hypertension adherence program in pharmacy (HAPPY trial): Baseline data; Pharmacy Practice Research Summit 2010
Hypertension adherence program in pharmacy (HAPPY Trial): Methodology; Pharmacy Practice Research Summit 2010
Identifying barriers to the implementation of an electronic system designed for documenting clinical interventions within community pharmacies ; APSA Annual Conference Aus-CRS Symposium Hobart
Impact of partnered pharmacist medication charting (PPMC) on medication discrepancies and errors: A pragmatic evaluation of an emergency department-based process redesign; International Journal of Environmental Research and Public Health
Impact of partnered pharmacist medication charting in the Royal Hobart Hospital emergency department on medication discrepancies and errors: preliminary results; APSA 2021 Annual Conference
Impact of partnered pharmacist medication charting on potentially inappropriate medication use; APSA-ASCEPT 2022
Impact of partnered pharmacist medication charting on potentially inappropriate medication use; APSA-ASCEPT 2022
Impact of pharmacist interventions provided in the emergency department on quality use of medicines: a systematic review and meta-analysis; Emergency Medicine Journal
Improving aspirin use among adults with diabetes; Australian Pharmacist
Improving clinical outcomes for hospital patients initiated on warfarin; Journal of Pharmacy Practice and Research
Improving knowledge and early detection of atrial fibrillation through a community-based opportunistic screening program: what's your beat?; International Journal of Environmental Research and Public Health
Improving Medication Adherence and Helping Patients Make Lifestyle Changes; JAMA Internal Medicine
Improving the management of warfarin in aged care facilities utilising an innovative IT solution; Medicines design to delivery
Improving the management of warfarin in aged-care facilities utilising innovative technology: a proof-of-concept study; International Journal of Pharmacy Practice
Improving the outcomes of anticoagulation in rural Australia: An evaluation of pharmacist-assisted monitoring of warfarin therapy; Journal of Clinical Pharmacy and Therapeutics
Improving the quality use of anticoagulants
Improving the use of prophylaxis for venous thromboembolism at the Royal Hobart Hospital; National Medicines Symposium 2006 - Quality use of medicines: balancing beliefs, benefits and harms
Incretin-based therapies; Australian Pharmacist
Infant formulas; Australian Pharmacist
Infective Conjunctivitis; Australian Pharmacist
Inflammatory bowel disease; Australian Pharmacist
Inhaled anticholinergic medications: their role in COPD and adverse cardiovascular events; Australian Pharmacist
Initial diagnosis and management of chronic obstructive pulmonary disease in Australia: views from the coal face; Internal Medicine Journal
Innovative communication strategies to manage chronic disease or high-risk medications; National Medicines Symposium 2009
Innovative IT solutions to improve the management of warfarin; National Medicines Symposium 2009
INR and practical patient care; Pharmacy Expo 2010
INR point of care testing; The Australian Institute of Medical Scientists Annual Scientific Meeting
INR Self Monitoring Training Workshop; AACP Consultant Pharmacy Clinial Seminar
Integrating pharmacy and registry data strengthens clinical assessments of patient adherence; Frontiers in Pharmacology
Knowledge, beliefs and management of childhood fever among nurses and other health professionals: a cross-sectional survey; Nurse Education Today
Management of hypertension; Australian Pharmacist
Management of pain in surgical patients post discharge - who is responsible for the provision of advice?; International Association for the Study of Pain 16th biannual World Congress on Pain
Managing attention deficit hyperactivity disorder in children; Australian Pharmacist
Managing glycaemia in type 2 diabetes; Australian Pharmacist
Medication adherence following acute coronary syndrome: does one size fit all?; American Journal of Cardiovascular Drugs
Medication prescribing quality in Australian primary care patients with chronic kidney disease; Journal of Clinical Medicine
Medication regimen complexity index prediction of adverse drug reaction–related hospital admissions; The Annals of Pharmacotherapy
Medications used in assisted reproduction; Australian Pharmacist
Medicine-induced pulmonary toxicity; Australian Pharmacist
Melanoma; Australian Pharmacist
More blood, sweat and tears: a qualitative analysis of warfarin management after discharge from hospital; Across the divide medicines management 2009 The 35th SHPA National Conference
Mortality from adverse drug reaction-related hospitalizations in south-west Ethiopia: A cross-sectional study; Journal of Clinical Pharmacy and Therapeutics
Multimorbidity and the elderly; Australian Pharmacist
Multivitamins and breast cancer risk – no need to panic; Australian Pharmacist
New antithrombotics for Atrial Fibrillation; Cardiovascular Therapeutics
New Investigator Presentations: Improving the quality use of anticoagulants; Pharmacy Australia Congress 2007
New medications to treat type 2 diabetes; Australian Pharmacist
Non-adherence to thromboprophylaxis guidelines in Atrial fibrillation: a narrative review of the extent of and factors in guideline non-adherence; American Journal of Cardiovascular Drugs
Non-melanoma skin cancer; Australian Pharmacist
Novel oral anticoagulants in atrial fibrillation; Australian Pharmacist
Opioid use in Australian nursing home residents; 5th Association of South-East Asian Pain Societies Conference
Opioid use in community dwelling elderly in Australia; 5th Association of South-East Asian Pain Societies Conference
Opioid use in elderly community and nursing home patients; 5th Association of South-East Asian Pain Societies Conference
Oral anticoagulant treatment and the risk of dementia in patients with atrial fibrillation: a population-based cohort study; Journal of the American Heart Association
Oral anticoagulant use in patients with atrial fibrillation: pre- vs. post-direct oral anticoagulant era comparisons; ESC Congress 2017
Outcomes of a pharmacist-led post discharge warfarin management service: adverse events, warfarin knowledge and patient satisfaction; SEiR 2010 Postgraduate Research Conference - Sharing excellence in research
Outcomes of a Pharmacist-led post-discharge warfarin management service; Pharmacy Australia Congress 2010
Outcomes of a pharmacist-led post-discharge warfarin management service; National Medicines Symposium 2010 medicines in people’s lives
Outcomes of a pharmacist-led post-discharge warfarin management service; Pharmacy Australia Congress 2010
Outcomes of a pharmacist-led post-discharge warfarin management service adverse events, warfarin knowledge and patient satisfaction; Society of Hospital Pharmacists of Australia 2010 Tasmanian Branch Symposium
Outcomes of medication misadventure among people with cognitive impairment or dementia: a systematic review and meta-analysis; The Annals of Pharmacotherapy
Over-use of antibiotics for acute otitis media; Australian Pharmacist
Pain and functionality following sternotomy: a prospective 12-month observational study; Pain Medicine
Pain intensity and pain self-management strategies following discharge after surgery: An Australian prospective observational study; Journal of Clinical Pharmacy and Therapeutics
Parental knowledge, beliefs and management of childhood fever in Australia: a nationwide survey; Journal of Clinical Pharmacy and Therapeutics
Patient characteristics and antithrombotic prescribing patterns in patients with atrial fibrillation in Tasmania; Clinical and Applied Thrombosis - Hemostasis
Patient experiences with gabapentinoid therapy for persistent pain; Australasian Pharmaceutical Science Association Conference
Patient self-monitoring of anticoagulation: a follow up study; HAA 2010 Annual Scientific Meeting
Patient self-monitoring of anticoagulation: a follow-up study; 11th national conference on anticoagulant therapy
Patient uptake and outcomes following pharmacist-initiated referrals to general practitioners for asthma review; n p j Primary Care Respiratory Medicine
Persistence of Adverse drug reaction-related hospitalization risk following discharge; International journal of environmental research and public health
Persistent pain management in Australian general practice; Australian Journal of Primary Health
Persistent post-operative pain and its influence on preoperative pain management; International Association for the Study of Pain 16th biannual World Congress on Pain
Pharmacist-delivered asthma management services - what do patients think?; Journal of the American Pharmacists Association
Pharmacist-led interventions to reduce adverse drug events in older people living in residential aged care facilities: a systematic review; British Journal of Clinical Pharmacology
Pharmacists experience of and perspectives about recruiting patients into a community pharmacy asthma service trial; Research in Social and Administrative Pharmacy
Pharmacist’s interventions to reduce the occurrence of drug-related harms in older residents: a systematic review; APSA 2021 Annual Conference
Pharmacological management of pain in Australian Aged Care Facilities; Age and Ageing
Pharmacy based model enabling patient self monitoring of warfarin: Development and evaluation; Pharmacy Practice Research Summit 2010
Pharmacy Simulator: A 3D computer-based virtual patient simulator for training community pharmacists; Pharmacy Simulator: A 3D computer-based virtual patient simulator for training community pharmacists
Pharmacy Simulator: A 3D computer-based virtual patient simulator for training community pharmacists; 2015 Joint APSA-ASCEPT Annual Conference
Point of Care INR Monitoring; Pharmacy Expo 2011
Point-of-care testing; Australian Prescriber
Post traumatic stress disorder; Australian Pharmacist
Potential use of NOACs in developing countries: pros and cons; European Journal of Clinical Pharmacology
PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation; Journal of Clinical Pharmacy and Therapeutics
Practical aspects of anti-platelet therapy; AACP’s 6th annual consultant pharmacy clinical seminar
Practising pharmacists want more nutrition education; Currents in Pharmacy Teaching and Learning
Prediction of hospitalization due to adverse drug reactions in elderly community-dwelling patients (The PADR-EC Score); PLoS One
Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study; PLoS One
Prescribing of psychotropic medication for nursing home residents with dementia: a general practitioner survey; Clinical Interventions in Aging
Preventing adverse drug reactions after discharge: protocol for a randomised controlled trial in older people; APSA 2021 Annual Conference
Preventing adverse drug reactions after hospital discharge (PADR-AD): Protocol for a randomised-controlled trial in older people; Research in Social and Administrative Pharmacy
Preventing age-related macular degeneration; Australian Pharmacist
Preventing age-related macular degeneration; Australian Pharmacist
Preventing osteoporosis-related fractures; Australian Pharmacist
Prevention and treatment of drug-resistant Staphylococcus aureus; Australian Pharmacist
Primary open-angle glaucoma; Australian Pharmacist
PROMISe to document clinical interventions in Australian community pharmacies; Australian Pharmacist
Promoting antimicrobial stewardship in the community - are nurses an untapped resource?; NPS MedicineWise Conference, National Medicine Symposium (NMS)
Prospective identification versus administrative coding of adverse drug reaction‐related hospitalizations in the elderly: a comparative analysis; Pharmacoepidemiology and Drug Safety
Protection of the public or protection of the pharmaceutical industry?; Australian Prescriber
Readmissions to hospital due to adverse drug reactions in elderly Australians; ISPOR 22nd Annual International Conference
Reasons for non-adherence to thromboprophylaxis prescribing guidelines in atrial fibrillation in Western Australia: a qualitative descriptive study of general practitioners' views; Thrombosis Research
Recent issues with paracetamol: don't throw the baby out with the bathwater; Australian Pharmacist
Reducing harm associated with warfarin therapy. A national medication safety breakthrough project; SHPA Tasmanian State Branch 2005 Conference
Reducing harm associated with warfarin therapy: a national medication safety collaborative project; Medicines managers: the next generation
Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome; BMJ open
Refinement of an innovative web-based anticoagulation resource; Australasian Pharmaceutical Science Association Annual Conference
Refinement of the design of an electronic system to record community pharmacy interventions; APSA annual Conference Aus-CRS Symposium Hobart
Repeat adverse drug reaction-related hospital admissions in elderly Australians: a retrospective study at the Royal Hobart Hospital; Drugs & Aging
Repeat Adverse Drug Reactions-related Hospital Admissions in Elderly Australians; International Society for Pharmacoeconomics and Outcomes Research 22nd Annual International Meeting
Response to Re: Are the national orthopaedic thromboprophylaxis guidelines appropriate?; ANZ Journal of Surgery
Rethinking the gold standard - The feasibility of randomized controlled trials within health services effectiveness research; Research in social & administrative pharmacy : RSAP
Review of the initiation of warfarin in Tasmania; SHPA Tasmanian State Branch 2005 Conference
Review of the management of childhood asthma in Tasmania; Journal of Paediatrics and Child Health
Rheumatoid Arthritis; Australian Pharmacist
Short-term outcomes of usual care in patients taking warfarin after discharge from hospital; Pharmacy Practice Research Summit 2010
SMART-AF: Development of a decision support smartphone app to improve antithrombotic prescribing in atrial fibrillation; 2015 Joint APSA-ASCEPT Annual Conference
SMART-AF: Development of a decision support smartphone app to improve antithrombotic prescribing in atrial fibrillation; 2015 Joint APSA-ASCEPT Annual Conference
Smoking cessation; AusPharm Continuing Education
Statins as primary prevention in patients without dislipidaemia; Australian Pharmacist
Statins in the elderly; Australian Pharmacist
Strategies for improving guideline adherence of anticoagulants for patients with atrial fibrillation in primary healthcare: A systematic review; Thrombosis Research
Strategies to manage asthma; Australian Pharmacist
Strategies to manage COPD; Australian Pharmacist
Stroke prevention in atrial fibrillation: Novel anticoagulants; Australian Pharmacist
Stroke prevention – anticoagulation for atrial fibrillation; Australian Pharmacist
Stroke risk reassessment and oral anticoagulant initiation in primary care patients with atrial fibrillation: a ten-year follow-up; European Journal of Clinical Investigation
Subacute pain as a predictor of long-term pain following orthopedic surgery: an Australian prospective 12 month observational cohort study; Medicine
Suboptimal use of oral anticoagulants in atrial fibrillation: has the introduction of direct oral anticoagulants improved prescribing practices?; American Journal of Cardiovascular Drugs
Substituting phenylephrine for pseudoephedrine as a nasal decongestant: is it evidence-based?; Australian Pharmacist
Supervised patient self-testing of Warfarin therapy using an online system; Journal of Medical Internet Research
Switching of oral anticoagulants in atrial fibrillation: a cohort study using Australian general practice data; Expert Review of Clinical Pharmacology
Switching of oral anticoagulants in patients with nonvalvular atrial fibrillation: A narrative review; British Journal of Clinical Pharmacology
Targeting medication review services; Australian Pharmacist
Tasmanian hospital clinicians' attitudes regarding stroke prevention in atrial; Medicines Management 2015: The 41st SHPA National Conference
Ten-year trends in adverse drug reaction-related hospitalizations among people with dementia; Therapeutic Advances in Drug Safety
Ten-year trends in prescribing of antiarrhythmic drugs in Australian primary care patients with atrial fibrillation; Internal Medicine Journal
Ten-Year trends in the use of oral anticoagulants in Australian general practice patients with atrial fibrillation; Frontiers in Pharmacology
The basics of evidence-based medicine; Australian Pharmacist
The benefits of pharmacist-delivered warfarin education in the home; International Journal of Pharmacy Practice
The burden of hospital admissions for adverse drug reactions in Tasmania; National Medicines Symposium 2021
The current status of veterans taking warfarin; HAA-ISHAPD 2011
The direct thrombin inhibitor melagatran/ximelagatran; Medical Journal of Australia
The effect of knowledge and expectations on adherence to and persistence with antidepressants; Patient Preference and Adherence
The effect of knowledge and expectations on adherence to and persistence with antidepressants; APSA 2014 Annual Conference
The enigma of aspirin in primary prevention; Australian Pharmacist
The HAPPY Trial: a community pharmacy - based intervention for improving patient adherence to antihypertensive medicines; National Medicines Symposium 2010
The Persistence of opioid use following surgical admission: an Australian single-site retrospective cohort study; Journal of Pain Research
The quality of advice provided by pharmacists to patients taking direct oral anticoagulants: a mystery shopper study; Pharmacy
The quality of international normalised ratio control in southern Tasmania; Medical Journal of Australia
The relationship between anticoagulation knowledge, health literacy and medication adherence in patients with atrial fibrillation; APSA Annual Conference 2016
The relationship between knowledge, health literacy and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation; Cardiovascular therapeutics
The risk of symptomatic venous thromboembolism in hospitalised patients with active cancer; Australasian Pharmaceutical Science Association Conference
The risk of symptomatic venous thromboembolism in hospitalised patients with active cancer; National Medicines Symposium 2009
The risks of warfarin use in the elderly; Expert Opinion on Drug Safety
The role of community pharmacy in post hospital management of patients initiated on warfarin; Pharmacy Practice Research Summit 2010
The role of newer antidepressants in treating major depression; Australian Pharmacist
The Tasmanian Atrial Fibrillation Study (TAFS): Differences in Stroke Prevention According to Sex; The Annals of Pharmacotherapy
The Tasmanian Atrial Fibrillation Study: Transition to direct oral anticoagulants 2011-2015; Cardiovascular Therapeutics
The Tasmanian Atrial Fibrillation Study: Transition to Direct Oral Anticoagulants, 2011-2015; APSA Annual Conference 2016
The use of thromboprophylaxis for venous thromboembolism (VTE) in hospitalised medical patients; Annual Scientific Meeting of the: Haematology Society of Aust and NZ, Aust and NZ Society of Blood Transfusion and the Aust Soc of Thrombosis and Haemostasis
The use of thromboprophylaxis for venous thromboembolism in hospitalised medical patients at the Royal Hobart Hospital; SHPA Tasmanian State Branch 2005 Conference
The Utilisation of Antithrombotic Therapy in Older Patients in Aged Care Facilities with Atrial Fibrillation; APSA Annual Conference 2016
The utilization of antithrombotic therapy in older Australians with atrial fibrillation; Clinical and Applied Thrombosis/Hemostasis
The utilization of antithrombotic therapy in older patients in aged care facilities with atrial fibrillation; Clinical and Applied Thrombosis/Hemostasis
The warfarin home-monitoring pilot study; National Medicines Symposium 2006 - Quality use of medicines: balancing beliefs, benefits and harms
Therapeutic catch 22 - Warfarin use in the elderly; Australian Pharmacist
Therapeutic Update: Warfarin; The Australian Association of Consultant Pharmacy Accredited Pharmacists Forum
Thromboembolism and mortality in the Tasmanian Atrial Fibrillation Study; Journal of cardiovascular pharmacology and therapeutics
Thromboprophylaxis and venous thromboembolism following lower limb orthopaedic surgery at an Australian hospital; National Medicines Symposium 2010
Thromboprophylaxis following arthroplasty surgery; ERA 2010: National conference of emerging researchers in ageing
Thromboprophylaxis following hip and knee arthroplasty; Internal Medicine Journal
Thromboprophylaxis in medical patients; The Society of Hospital Pharmacists of Australia 5th Biennial Clinical Conference
Training Australian pharmacists for participation in a collaborative, home-based post-discharge warfarin management service; Pharmacy World & Science
Turning back time with botulinum toxin; Australian Pharmacist
Under-use of ACE-inhibitor and B-Blocker therapies in congestive cardiac failure; Australian Pharmacist
Under-use of B-Blockers; Australian Pharmacist
Under-utilisation of COPD management guidelines in Australian general practice; Thoracic Society of Australia and New Zealand annual scientific meeting
Understanding non-randomised study designs; Australian Pharmacist
Understanding randomised controlled trials; Australian Pharmacist
Understanding Systematic Reviews; Australian Pharmacist
Understanding the discrepancy between perceived and actual asthma control in Australia; 2015 Joint APSA-ASCEPT Annual Conference
Urinary incontinence; Australian Pharmacist
Use of opioid analgesics in older Australians; Pain Medicine
Venous thromboembolism: under-use of prophylaxis for medical and nursing home patients; Australian Pharmacist
Very-low calorie diets: a review of the evidence; Australian Pharmacist
Vitamin supplements in the elderly; Australian Pharmacist
Warfarin management after discharge from hospital: a qualitative analysis; Journal of Clinical Pharmacy and Therapeutics
Warfarin management in Australia: what can pharmacists offer?; Australian Pharmacist
Weight management; Australian Pharmacist
When asthma and COPD overlap each other; Australian Pharmacist
Which is the safest NSAID for patients at elevated cardiovascular risk?; Australian Pharmacist
Who is responsible for the care of patients treated with warfarin therapy?; The Medical Journal of Australia
With great power comes great responsibility; Medical Journal of Australia
Wound Care in Practice; Pharmaceutical Society of Australia Ltd
Xerostomia; Australian Pharmacist
Ximelagatran cost effectiveness for stroke prevention in atrial fibrillation; Journal of Pharmacy Practice and Research

Research Projects

'What's your beat?': Reducing strokes through AF awareness and screening; Tasmanian Community Fund (TasCF)
A fresh look at local practice to prevent blood clots following hip and knee replacement surgery; Royal Hobart Hospital Research Foundation (RHHRF)
Adverse drug reaction-related hospital admission in elderly Australians with dementia; Royal Hobart Hospital Research Foundation (RHHRF)
Adverse Drug Reactions as a Cause of Hospital Admission in the Elderly; University of Tasmania (UTAS)
Blood clots in Tasmanian cancer patients: what is the risk and how effectively are we preventing them?; Royal Hobart Hospital Research Foundation (RHHRF)
Development and Implementation of a Flexible Anticoagulation Monitoring Service for Rural Community Pharmacies; Department of Health and Aged Care (DHA)
Development of a decision support smartphone app to improve antithrombotic prescribing in atrial fibrillation; Royal Hobart Hospital Research Foundation (RHHRF)
Documenting Clinical Interventions in Community Pharmacy - PROMISE 3; Department of Health and Aged Care (DHA)
Does hospital opioid prescribing increase the risk of chronic opioid use?; Royal Hobart Hospital Research Foundation (RHHRF)
Educating Tasmanians about anticoagulant medications; Tasmanian Community Fund (TasCF)
Evidence to Practice Gap: Factors that Influence Practices to Prevent Blood Clots Following Hip and Knee Replacement Surgery; Royal Hobart Hospital Research Foundation (RHHRF)
Factors Influencing the Outcomes of Therapy with the Anti-clotting medication, Clopidogrel, in Patients with Acute Coronary Syndromes; Royal Hobart Hospital Research Foundation (RHHRF)
Games for Health: A technology platform for health and wellbeing (G4HEALTH); University of Tasmania (UTAS)
Getting Asthma Under Control; Department of Health (Cth) (DoH)
Impact of community pharmacy services on screening for chronic kidney disease; Tasmanian Community Fund (TasCF)
Increasing Community Pharmacy Involvement in the Prevention of Cardiovascular Disease; Department of Health and Aged Care (DHA)
Investigating the burden of childhood fever on Tasmanian families and the Royal Hobart Hospitals Emergency Department.; Royal Hobart Hospital Research Foundation (RHHRF)
Management of post-operative pain and the progression to persistent post-operative pain; Royal Hobart Hospital Research Foundation (RHHRF)
Medication Reviews ReDirected: Acute Coronary Syndromes as an Indication for Home Medicine Review, a randomised controlled trial; University of Tasmania (UTAS)
Outcomes of antithrombotic therapy in a new era: the Tasmanian experience; Royal Hobart Hospital Research Foundation (RHHRF)
Persistence with and Attitudes Towards INR Self-Monitoring Following Mechanical Heart Valve Insertion: Informing the Development of a Structured Training Program; University of Tasmania (UTAS)
Pharmacy-Based Model Enabling Patient Self-Monitoring of Warfarin: Development and Evaluation; Department of Health and Aged Care (DHA)
Preventing Adverse Drug Reactions in the Elderly; HCF Health and Medical Research Foundation (HCF)
ReMInDAR Trial Reducing Medicine Induced Deterioration and Adverse Reactions Trial; Department of Health (Cth) (DoH)
Rising Star; University of Tasmania (UTAS)
Supporting Rural Practitioners: Pharmacy-based Support Mechanisms for Drug Misuse in Rural and Remote Communities; Department of Health and Aged Care (DHA)
The Current Status of Management of Australian Veterans Taking Warfarin; Commonwealth Department of Veterans Affairs (DVA)
The Role of Community Pharmacy in Post Hospital Management of Patients Initiated on Warfarin; Department of Health and Aged Care (DHA)
A Review of the Management of Childhood Asthma in Tasmania
Alternative Methods of Confirming HbA1c
Clinical Interventions in Pharmacy Online Training Materials
Clinical Interventions Workshop
Development and Maintenance of an Online Resource - Anticoagulation (Phase 1)
Development and Maintenance of an Online Resource - Anticoagulation (Phase 2)
Development of a Smoking Cessation Educational Program for Pharmacists and Pharmacy Assistants
DVT Prophylaxis Study
Fucoidan and marine polyphloroglucinols
Improving the management of warfarin in aged care facilities utilising an innovative ICT solution
Medicines Australia Continuing Education Program
Pharmaceutical Society of Australia Co-funded Scholarship
Pharmacy Oral Examination: Examiner Training Development
Professional Practice Standards and Practice Guidelines for Clinical Interventions
Review of APF 22
Warfarin Booklet Rewrite
Warfarin Booklet Rewrite

Research Candidate Supervision

A Prospective Study on Nature and Pattern of the Occurence of Adverse Drug Events with the Use of Cardiovascular Drugs
A Retrospective Cohort Study Evaluating The Trend in Opiod Use in Tasmania From 2001-2010
A Retrospective Study of Adverse Drug Reactions Ocurring in Elderly Patients at Tertiary Hospitals, Tasmania, Australia
Adverse Drug Reactions and Associated Factors in Adult HIV Positive Patients Treated with Highly Active Antiretroviral Therapy in Gondar University and Felege-Hiwot Hospitals, Ambarra Region, Ethiopia
An Investigation of the Significant Role of Pharmacists in Improving the Quality of Palliative Care Service in North West Tasmania
Analysis of Fucoidan and Its Potential Utility in Diabetes Management
Community Pharmacy Screening and Medication Management in Chronic Kidney Disease
Genetic Resistance to Treatment with Clopidogrel
Implementation of a pharmacist medication review clinic for renal disease patients
Optimising Warfarin Management- An Exploration of Pharmacist-delivered Models of Care
The Outcomes of Clopidogrel Therapy in Patients with ACS in Southern Tasmania
The Role of Community Pharmacy in Post-Discharge Warfarin Management
Thromboprophylaxis Following Hip and Knee Arthroplasty